Free Trial

Oragenics (OGEN) SEC Filings & 10K Form

Oragenics logo
$0.29 +0.00 (+1.03%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.28 0.00 (-0.95%)
As of 02/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Oragenics SEC Filings

DateFilerForm TypeView
02/18/2025
3:30 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:05 PM
Oragenics (Filer)
Form RW
01/21/2025
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
11:15 PM
Oragenics (Filer)
Form EFFECT
01/08/2025
5:06 AM
Oragenics (Filer)
Form S-1/A
12/31/2024
10:47 AM
Oragenics (Filer)
Form S-1/A
12/19/2024
9:00 AM
Oragenics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/16/2024
3:05 PM
Oragenics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/16/2024
3:10 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
5:07 PM
DUNTON ALAN W (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:23 PM
Oragenics (Issuer)
Telling Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
3:35 PM
Oragenics (Subject)
Telling Fred (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
1:04 PM
DUNTON ALAN W (Reporting)
Oragenics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2024
4:00 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:29 PM
Lind Global Fund II LP (Filed by)
Oragenics (Subject)
Form SC 13G/A
11/13/2024
1:40 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
8:20 AM
Oragenics (Filer)
Form DEFA14A
10/31/2024
8:15 AM
Oragenics (Filer)
Form DEF 14A
10/18/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
9:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:25 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:45 PM
Oragenics (Filer)
Form 424B5
10/09/2024
6:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
8:15 PM
Oragenics (Issuer)
Telling Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Murphy Kimberly M (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Cassidy Bruce A. Sr. (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
KOSKI ROBERT C (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
DUNTON ALAN W (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
GANDOLFO JOHN P (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Oragenics (Issuer)
POPE CHARLES L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Oragenics (Issuer)
REDMOND J MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:15 PM
Huffman Janet (Reporting)
Oragenics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:45 AM
Iroquois Capital Management, LLC (Filed by)
Oragenics (Subject)
Form SC 13G
09/05/2024
3:45 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
7:26 AM
Oragenics (Filer)
Form 424B5
09/03/2024
11:15 PM
Oragenics (Filer)
Form EFFECT
08/21/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:30 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

08/09/2024
3:30 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:30 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:35 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:30 PM
Oragenics (Filer)
Form 424B5
06/20/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
8:27 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:00 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
12:00 PM
Oragenics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
7:14 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
7:01 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:16 PM
Oragenics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
6:38 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
3:24 PM
Lind Global Fund II LP (Filed by)
Oragenics (Subject)
Form SC 13G
03/01/2024
3:05 PM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
8:03 AM
Oragenics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:OGEN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners